Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on
the lives and health of people around the globe. As of 4 July 2021, more than 183 million …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

Aim COVID-19 clinical presentation is heterogeneous, ranging from asymptomatic to severe
cases. While there are a number of early publications relating to risk factors for COVID-19 …

Objective To evaluate association between biomarkers and outcomes in COVID-19
hospitalised patients. COVID-19 pandemic has been a challenge. Biomarkers have always …

Although COVID-19 presents primarily as a lower respiratory tract infection transmitted via
air droplets, increasing data suggest multiorgan involvement in patients that are infected …

Various comorbidities represent risk factors for severe coronavirus disease 2019 (COVID‐
19). The impact of smoking on COVID‐19 severity has been previously reported in several …

In view of the emerging COVID‑19 pandemic caused by SARS‑CoV‑2 virus, the search for
potential protective and therapeutic antiviral strategies is of particular and urgent interest …

Obesity is an emerging independent risk factor for susceptibility to and severity of
coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome …

Background Coronaviruses mainly affect the respiratory system; however, there are reports
of SARS-CoV and MERS-CoV causing neurological manifestations. We aimed at discussing …

Purpose Severe acute respiratory coronavirus 2 (SARS-CoV-2) cases are overgrowing
globally and now become a pandemic. A meta-analysis was conducted to evaluate the …